Moisturizer and skin hydration for teenage eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a common moisturizer (CeraVe cream) to see how well it hydrates the skin on the forearms of teens with eczema. You'll use the moisturizer regularly and we'll check your skin's moisture over several visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atopic dermatitis (eczema).
- You are between 12 and 18 years old.
- You can bathe by yourself.
- You speak English and can fill out questionnaires.
- You have not used steroid creams on your forearms in the past month, and you won't use them during the study.
- You are not allergic to the CeraVe moisturizing cream used in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using CeraVe moisturizer can keep your skin hydrated and prevent flare-ups after your eczema has been cleared with a steroid treatment. It is for adults with mild to moderate eczema that gets better with steroids.
This study tests a new cream called JYP0066 for people with mild-to-moderate atopic dermatitis (eczema). It aims to see if the cream safely reduces itching and skin inflammation. It might help if you have tried other creams and still have symptoms.
This trial tests if a special cream made with a milk protein peptide can improve mild eczema symptoms like itching and reduce bacteria on the skin in children aged 2 to 12.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This study tests a new medication called VC005 to treat atopic dermatitis (eczema)—a skin condition causing itching, redness, and inflammation. Researchers want to see if VC005 can safely reduce symptoms in people aged 12 and older with mild-to-moderate cases.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
Hear when a new Atopic Dermatitis (Eczema) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.